Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Segovia

Showing results (101-110 of 220) with videos related to

Pageof 22
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 8, 2006
Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter studyJon A Kobashigawa, Dale G Renlund, Gino Gerosa, et al.
Revista Espanola De Cardiologia (English Ed.)|April 30, 2014
Characteristics of patients with survival longer than 20 years following heart transplantationNatalia Jaramillo, Javier Segovia, Manuel Gómez-Bueno, et al.
Medicina Clinica|May 9, 2008
[Usefulness of natriuretic peptides in heart failure]Manuel Jiménez-Navarro, Juan Delgado Jiménez, Miguel Rivera Otero, et al.
Transplantation|December 14, 2006
A review of critical periods for opportunistic infection in the new transplantation eraRafael San Juan Garrido, Jose M Aguado, Carmen Díaz-Pedroche, et al.
Revista Espanola De Cardiologia (English Ed.)|April 14, 2018
Prognostic Impact and Predictors of Ejection Fraction Recovery in Patients With Alcoholic CardiomyopathyAlmudena Amor-Salamanca, Gonzalo Guzzo-Merello, Esther González-López, et al.
Clinical Transplantation|October 24, 2025
Impact of Pre-Heart Transplant Levosimendan Administration on Post-Transplant Vasoplegia and Primary Graft DysfunctionJoan Guzman-Bofarull, Alba Martín-Centellas, David Couto-Mallon, et al.
The European Respiratory Journal|February 25, 2012
Survival in pulmonary hypertension in Spain: insights from the Spanish registryPilar Escribano-Subias, Isabel Blanco, Manuel López-Meseguer, et al.
European Journal of Heart Failure|September 8, 2011
Genetic basis of end-stage hypertrophic cardiomyopathyPablo Garcia-Pavia, Maria E Vázquez, Javier Segovia, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 8, 2011
RADIAL: a novel primary graft failure risk score in heart transplantationJavier Segovia, M Dolores G Cosío, Juan M Barceló, et al.
Frontiers in Cardiovascular Medicine|April 25, 2022
Lack of Usefulness of Donor-Derived Cell-Free DNA as a Biomarker for Cardiac Allograft Vasculopathy: A Prospective StudyMarta Jiménez-Blanco Bravo, Laura Pérez-Gómez, Francisco J Hernández-Pérez, et al.
Pageof 22

Showing results (101-110 of 220) with videos related to

Sort By:
Pageof 22
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 8, 2006
Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter studyJon A Kobashigawa, Dale G Renlund, Gino Gerosa, et al.
Revista Espanola De Cardiologia (English Ed.)|April 30, 2014
Characteristics of patients with survival longer than 20 years following heart transplantationNatalia Jaramillo, Javier Segovia, Manuel Gómez-Bueno, et al.
Medicina Clinica|May 9, 2008
[Usefulness of natriuretic peptides in heart failure]Manuel Jiménez-Navarro, Juan Delgado Jiménez, Miguel Rivera Otero, et al.
Transplantation|December 14, 2006
A review of critical periods for opportunistic infection in the new transplantation eraRafael San Juan Garrido, Jose M Aguado, Carmen Díaz-Pedroche, et al.
Revista Espanola De Cardiologia (English Ed.)|April 14, 2018
Prognostic Impact and Predictors of Ejection Fraction Recovery in Patients With Alcoholic CardiomyopathyAlmudena Amor-Salamanca, Gonzalo Guzzo-Merello, Esther González-López, et al.
Clinical Transplantation|October 24, 2025
Impact of Pre-Heart Transplant Levosimendan Administration on Post-Transplant Vasoplegia and Primary Graft DysfunctionJoan Guzman-Bofarull, Alba Martín-Centellas, David Couto-Mallon, et al.
The European Respiratory Journal|February 25, 2012
Survival in pulmonary hypertension in Spain: insights from the Spanish registryPilar Escribano-Subias, Isabel Blanco, Manuel López-Meseguer, et al.
European Journal of Heart Failure|September 8, 2011
Genetic basis of end-stage hypertrophic cardiomyopathyPablo Garcia-Pavia, Maria E Vázquez, Javier Segovia, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 8, 2011
RADIAL: a novel primary graft failure risk score in heart transplantationJavier Segovia, M Dolores G Cosío, Juan M Barceló, et al.
Frontiers in Cardiovascular Medicine|April 25, 2022
Lack of Usefulness of Donor-Derived Cell-Free DNA as a Biomarker for Cardiac Allograft Vasculopathy: A Prospective StudyMarta Jiménez-Blanco Bravo, Laura Pérez-Gómez, Francisco J Hernández-Pérez, et al.
Pageof 22